Welcome to our dedicated page for VSee Health news (Ticker: VSEE), a resource for investors and traders seeking the latest updates and insights on VSee Health stock.
VSee Health, Inc. (NASDAQ: VSEE) is a telehealth technology and services company whose news flow centers on AI-powered virtual care, digital health infrastructure, and capital markets developments. As a health information services provider, VSee regularly issues updates on its telehealth platform, AI initiatives, hospital partnerships, and regulatory milestones, giving investors and healthcare stakeholders insight into how the business is evolving.
Company press releases highlight product and solution launches, such as the AI-enhanced Rural Health Transformation Solution designed for rural hospitals, and initiatives that apply VSee’s configurable digital health infrastructure to specialty access, clinical workflows, and financial performance. News items also cover collaborations with health systems on tele-urgent care, teleradiology, telenursing, and high-acuity virtual care programs, as well as international projects in regions like Southeast Asia where VSee’s platform supports maternal health, primary care, and tuberculosis screening efforts.
VSEE news frequently addresses AI and security credentials, including references to FedRAMP High Authority to Operate from the U.S. Department of Health and Human Services and FedRAMP Moderate authorization related to federal telehealth deployments. These updates help readers understand how VSee positions its telehealth and AI infrastructure for hospital systems, health networks, employers, and government partners.
In addition, VSee’s news feed includes financial and corporate disclosures that complement its SEC filings, such as announcements of private placements, equity line arrangements, convertible notes, and Nasdaq listing compliance updates. Readers following VSEE news can track how the company’s technology initiatives, service contracts, and financing activities intersect, and can return to this page to review new releases as they are published.
VSee Health (NASDAQ:VSEE) reported a 20-fold expansion of its hospital network to 58 locations, up from 3 over about two years. This expansion supported 2025 revenue of $11.4 million, an 80% increase. VSee focuses on enterprise telehealth via Integrated Delivery Network relationships and multi-year deployments.
According to VSee, the company aims for a $20 million annual revenue run-rate, sustained gross margins of at least 50%, and progress toward profitability as it targets reach into hundreds of hospitals over the next two years.
VSee Health (NASDAQ:VSEE) outlined business performance after the May 31, 2026 strategic sale of VSee Lab and renewed focus on its iDoc telehealth platform and enterprise healthcare solutions.
Pro-forma results show 2025 revenue up 60% to $8 million and Q1 2026 revenue up 70% to $2.5 million, alongside an approximate $6 million annual reduction in operating expenses.
Several large multi-year IDN contracts signed in 2025 are ramping and expanding telehealth services. Management believes targeting $20 million revenue and profitability over the next 12 months is realistic, citing improved margins and lower operating costs.
VSee Health (NASDAQ:VSEE) completed a strategic separation from its former lab subsidiary, VSee Lab, selling 100% of VSee Lab to former Co-CEO and Chairman Milton Chen.
Chen returned 2,870,069 VSee shares (about 7% of outstanding), which will be retired, and assumed remaining VSee Lab liabilities. Dr. Imoigele Aisiku becomes sole CEO and Chairman, with VSee Health focusing on its iDoc telehealth platform, enterprise healthcare solutions, AI-enabled care, and recurring revenue opportunities.
VSee Health (Nasdaq:VSEE) reported full-year 2025 results with revenue up 40% to $14,618,184 and a materially stronger balance sheet after debt-to-equity conversions. Cash and equivalents rose to $5,266,286 at year-end. The company said operating expenses fell sharply and management expects continued contract-driven growth in 2026.
The company noted multi-year institutional contracts (including a previously announced $10 million per year deal), FedRAMP High approval for VSee Labs, and ongoing telehealth rollouts across multiple states.
VSee (NASDAQ:VSEE) unveiled the VSee AI Robot at HIMSS 2026, a fully autonomous telehealth robot that navigates to patient bedsides without staff escort, using LiDAR and 30X optical/infrared night vision. Key capabilities include virtual rounding, telestroke response, programmable medication delivery, and integration via the no-code VSee AI Workflow Engine. The company cites platform scale: 1.5M video encounters/month and capacity for 1,800+ appointments/day, and promises customization timelines of 1 day to 1 month.
VSEE Health (NASDAQ:VSEE) announced a strategic managed services partnership with GoMyRx, an affiliate of GoMyDocs, to expand integrated digital healthcare delivery and telehealth-enabled medication fulfillment nationwide.
Under the agreement, GoMyRx will act as VSEE Health's primary operational integration partner for prescription workflow coordination, medication fulfillment, and direct-to-patient delivery, leveraging GoMyRx's national platform with annual gross transaction volume exceeding $10 million and GoMyDocs' compounding and logistics network. The integrated platform links VSEE Health's secure video visits, AI-assisted clinical workflows, remote patient monitoring, and EHR integrations with fulfillment operations to support scalable virtual care and medication delivery.
VSee Health (Nasdaq:VSEE) will host a live webinar, "The On‑Demand ICU: Sustainable Rural Healthcare", on February 4, 2026 at 11:00 AM PT / 2:00 ET. The session will discuss tele‑ICU and mobile ICU models for rural hospitals, staffing relief, clinician sustainability, and financial recovery.
Speakers include Docbox CEO Bobby Shah and VSee CEO Milton Chen. Topics highlight capturing up to $1M in recovered revenue over five years, automated vitals‑to‑EHR workflows, bi‑directional video, real‑time access to labs/PACS, and data/AI infrastructure for scalable remote ICU care.
VSee Health (Nasdaq:VSEE) announced a strategic partnership with DocBox to build the first AI-native, augmented‑intelligence Virtual ICU operating system for hospitals worldwide.
The joint platform embeds live bedside device data into VSee telehealth workflows to enable 24/7 remote ICU coverage, automated billing capture into the EHR, AI copilots on real physiology, and support for rural hospital programs.
VSee (Nasdaq:VSEE) launched an AI‑driven Rural Health Transformation Solution on January 12, 2026 to help rural hospitals expand specialty access, reduce avoidable transfers, and improve financial sustainability.
The modular platform combines Uber‑like specialist routing, AI clinical assistants, and predictive early‑warning systems. VSee modeled a representative 70‑bed hospital and estimated $6.6M annual revenue leakage from transfers and up to $5.3M potential annual retention; an additional $300k–$1.6M annual opportunity from reduced patient bypass was noted.
The solution targets alignment with the CMS Rural Health Transformation Program ($10B/year for five years) and will be discussed at the J.P. Morgan Healthcare Conference Jan 12–15, 2026.
VSee Health (NASDAQ:VSEE) announced it is postponing its 2025 Annual Meeting of Stockholders from December 15, 2025 at 2:30 p.m. ET to December 30, 2025 at 2:30 p.m. ET because it does not anticipate a quorum.
The meeting will be held via live webcast at https://www.cstproxy.com/vseehealth/2025. The record date remains November 20, 2025. Stockholders who already voted do not need to act; those who have not voted are encouraged to vote by December 29, 2025 at 11:59 p.m. ET. No proposal changes were made.